secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0001729149-23-000110
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viemed Healthcare reports Q2 2023 record revenue of $43.3M, up 31% YoY
----------------------------------------------------------------------

- Net revenues of $43.3M for Q2 2023, a new Company record, up 31% YoY; HMP acquisition contributed $2.5M.
- Net income totaled $2.3M for the quarter ended June 30, 2023.
- Adjusted EBITDA of $9.8M for Q2 2023, a 52% increase over Q2 2022.
- Core net revenues (excluding HMP) grew approximately 9% sequentially from Q1 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914923000110/0001729149-23-000110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914923000110/vmd-20230809.htm
  HTML page:      https://secwatch.observer/filing/0001729149-23-000110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer